Patents

  • Patent Number Year Symeres Authors Customer
    Multiple D2 a(nta)gonists/H3 antagonists for treatment of CNS-related disorders WO 2015/069110 A1 2015 André Heeres, Mark Borst AAPA B.V.

    Read more

  • Patent Number Year Symeres Authors Customer
    Pesticidally active heterocyclic derivatives with sulphur containing substituents WO2015/144826 A1WO2015/144895 A1WO2016/113155 A1WO2016/012395 A1WO2017/016922 A1WO2017/050751 A1 2015 Ruud Titulaer Syngenta

    Read more

  • Patent Number Year Symeres Authors Customer
    Imidazo[1,2-a]pyridines as soluble guanylate cyclase stimulators for the treatment of cardiovascular diseases WO2015/165933 A3 2015 Dominika Bachera Bayer Pharma

    Read more

  • Patent Number Year Symeres Authors Customer
    Fused imidazolyl derivatives, their preparation and use as medicaments WO2015091795 2015 Piotr Nieczypor Esteve

    Read more

  • Patent Number Year Symeres Authors Customer
    Process for preparing a urea grease WO2014/122273 A1 2014 Don van Zwieten, Ton Visser Shell

    Read more

  • Patent Number Year Symeres Authors Customer
    Compounds for Protection of Cells WO2014/098586A1 2014 André Heeres, Jean-Paul Seerden Sulfateq BV

    Read more

  • Patent Number Year Symeres Authors Customer
    Chromanyl Derivatives for Treating Mitochondrial Disease WO2014011047A1 2014 Ruben Leenders, Geert Jan Sterk Khondrion

    Read more

  • Patent Number Year Symeres Authors Customer
    Geranyl geranyl acetone analogs and uses therof WO2013157955 A1 2013 André Heeres, Jean-Paul Seerden Nyken Holding B.V., University of Groningen

    Read more

  • Patent Number Year Symeres Authors Customer
    Acetylenic Microbiocides WO 2013 144224 2013 Ruud Titulaer Syngenta

    Read more

  • Patent Number Year Symeres Authors Customer
    4,5-Dihydro-isoxazole Derivatives as Fungicides WO 2012/143395 2012 Ruud Titulaer Syngenta

    Read more

Feel free to contact us!

Curious to know more about what can we do for you? Get in touch and let’s start a conversation.

Contact us